Access the full text.
Sign up today, get DeepDyve free for 14 days.
W. Ruka, P. Rutkowski, M. Krzakowski, Urszula Grzesiakowska, Konrad Ptaszyński, A. Jeziorski, W. Polkowski, J. Ryś, J. Słuszniak, W. Dziewirski, Tadeusz Morysiński, T. Świtaj, M. Bębenek, J. Siedlecki, J. Limon, Zbigniew Nowecki (2009)
Mięsaki tkanek miękkich u dorosłych - zasady postępowania diagnostyczno-terapeutycznegoNowotwory, 60
P Rutkowski, A Wozniak, M Dębiec-Rychter, M Kąkol, W Dziewirski, M Zdzienicki, K Ptaszynski, M Jurkowska, J Limon, JA. Siedlecki (2011)
Clinical utility of the new American Joint Committee on cancer staging system for gastrointestinal stromal tumors: Current overall survival after primary tumor resectionCancer., 117
S. Arya, D. Nagarkatti, S. Dudhat, K. Nadkarni, M. Joshi, S. Shinde (2000)
Soft tissue sarcomas: ultrasonographic evaluation of local recurrences.Clinical radiology, 55 3
D Labarre, R Aziza, T Filleron, M Delannes, F Delaunay, B Marques, G Ferron, C. Chevreau (2009)
Detection of local recurrences of limb soft tissue sarcomas: Is magnetic resonance imaging (MRI) relevant?Eur J Radiol, 72
P. Casali, L. Jost, P. Reichardt, M. Schlemmer, J. Blay (2009)
Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up.Annals of oncology : official journal of the European Society for Medical Oncology, 20 Suppl 4
A. Wheatley, Norman Howard (1967)
The surgical treatment of lung metastasesBritish Journal of Surgery, 54
K. Markou, A. Nikolaou, C. Themelis (2011)
National Comprehensive Cancer Network (NCCN) Head and Neck Cancers NCCN Clinical Practice Guidelines in Oncology . 2010.
P. Rutkowski, A. Wozniak, M. Debiec-Rychter, M. Kąkol, W. Dziewirski, M. Zdzienicki, K. Ptaszyński, M. Jurkowska, J. Limon, J. Siedlecki (2011)
Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumorsCancer, 117
Craig Gerrand, Lucinda Billingham, P. Woll, R. Grimer (2007)
Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United KingdomSarcoma, 2007
Shreyaskumar Patel, G. Zagars, P. Pisters (2003)
The follow-up of adult soft-tissue sarcomas.Seminars in oncology, 30 3
G. Ferron, R. Aziza, M. Delannes, T. Filleron, B. Marques, D. Labarre, C. Chevreau (2016)
Detection of local recurrences of limb soft-tissue sarcomas: Is magnetic resonance imaging (MRI) relevant?Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 15_suppl
R. Grimer, I. Judson, D. Peake, B. Seddon (2010)
Guidelines Guidelines for the Management of Soft Tissue Sarcomas
P Rutkowski, J Kulig, M Krzakowski (2010)
Recommendations for diagnostics and therapy of gastrointestinal stromal tumors (GIST) in 2010Onkol. Prakt. Klin, 6
A. Puri, A. Gulia, R. Hawaldar, P. Ranganathan, R. Badwe (2014)
Does Intensity of Surveillance Affect Survival After Surgery for Sarcomas? Results of a Randomized Noninferiority TrialClinical Orthopaedics and Related Research®, 472
P. Casali, L. Jost, P. Reichardt, M. Schlemmer, J. Blay (2008)
Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.Annals of oncology : official journal of the European Society for Medical Oncology, 19 Suppl 2
E. Ewing (2012)
Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Annals of oncology : official journal of the European Society for Medical Oncology, 23 Suppl 7
H. Joensuu, M. Eriksson, K. Hall, J. Hartmann, D. Pink, J. Schütte, G. Ramadori, P. Hohenberger, J. Duyster, S. Al-Batran, M. Schlemmer, S. Bauer, E. Wardelmann, M. Sarlomo‐Rikala, B. Nilsson, H. Sihto, O. Monge, P. Bono, R. Kallio, Aki Vehtari, M. Leinonen, T. Alvegård, P. Reichardt (2012)
One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.JAMA, 307 12
A. Briccoli, S. Galletti, M. Salone, Angelo Morganti, P. Pelotti, M. Rocca (2007)
Ultrasonography Is Superior to Computed Tomography and Magnetic Resonance Imaging in Determining Superficial Resection Margins of Malignant Chest Wall TumorsJournal of Ultrasound in Medicine, 26
A. Casson, J. Putnam, G. Natarajan, D. Johnston, C. Mountain, M. McMurtrey, J. Roth (1992)
Five‐year survival after pulmonary metastasectomy for adult soft tissue sarcomaCancer, 69
M. Brennan (2000)
Follow-Up Is Valuable and Effective: True, True and Unrelated?Annals of Surgical Oncology, 7
SR Patel, GK Zagars, PWT. Pisters (2003)
The follow-up of adult soft tissue sarcomasSem Surg Oncol, 30
K. Sakata, A. Beitler, J. Gibbs, W. Kraybill, Katherine Virgo, F. Johnson (2002)
How surgeon age affects surveillance strategies for extremity soft tissue sarcoma patients after potentially curative treatment.The Journal of surgical research, 108 2
Brian Whooley, Margaret Mooney, John Gibbs, W. Kraybill, W. Kraybill (1999)
Effective follow-up strategies in soft tissue sarcoma.Seminars in surgical oncology, 17 1
M. Gadd, E. Casper, J. Woodruff, P. McCormack, M. Brennan (1993)
Development and Treatment of Pulmonary Metastases in Adult Patients with Extremity Soft Tissue SarcomaAnnals of Surgery, 218
P. Rutkowski, J. Kulig, M. Krzakowski, C. Osuch, J. Siedlecki, A. Nasierowska-Guttmejer, J. Sygut, J. Limon, A. Jeziorski, U. Grzesiakowska, K. Ptaszyński, J. Słuszniak, W. Polkowski, E. Starosławska, M. Pólkowski, M. Bębenek, M. Matłok, K. Urbańczyk, W. Olszewski, S. Głuszek, Z. Nowecki (2010)
Recommendations for diagnostics and therapy of gastrointestinal stromal tumors (GIST) in 2010Oncology in Clinical Practice, 6
B. Whooley, John Gibbs, Margaret Mooney, Brian McGrath, W. Kraybill (2000)
Primary Extremity Sarcoma: What Is the Appropriate Follow-Up?Annals of Surgical Oncology, 7
Yi‐Sheng Chou, Chun-Yu Liu, Wei-Ming Chen, Tain-hsiung Chen, P. Chen, H. Wu, H. Chiou, C. Shiau, Yu-Chung Wu, Chien-Lin Liu, T. Chao, C. Tzeng, C. Yen (2012)
Follow‐up after primary treatment of soft tissue sarcoma of extremities: Impact of frequency of follow‐up imaging on disease‐specific survivalJournal of Surgical Oncology, 106
P. Reichardt, J. Blay, M. Mehren (2010)
Towards global consensus in the treatment of gastrointestinal stromal tumorExpert Review of Anticancer Therapy, 10
P. Cool, R. Grimer, R. Rees (2005)
Surveillance in patients with sarcoma of the extremities.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 31 9
(2013)
National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Soft Tissue Sarcomas, Version 1
A. Goel, M. Christy, Katherine Virgo, W. Kraybill, F. Johnson (2004)
Costs of follow-up after potentially curative treatment for extremity soft-tissue sarcoma.International journal of oncology, 25 2
R Grimer, I Judson, D Peake, B. Seddon (2010)
Guidelines for the management of soft tissue sarcomasSarcoma., 2010
W Ruka, P Rutkowski, M Krzakowski, U Grzesiakowska, K Ptaszyński, A Jeziorski, W Polkowski, J Ryś, J Słuszniak, W Dziewirski, T Morysiński, T Świtaj, M Bębenek, JA Siedlecki, J Limon, ZI. Nowecki (2010)
Soft tissue sarcomas in adult patients –guidelines for diagnosis and treatment.Nowotwory – Journal of Oncology, 60
Haesun Choi, D. Varma, B. Fornage, Eunjung Kim, D. Johnston (1991)
Soft-tissue sarcoma: MR imaging vs sonography for detection of local recurrence after surgery.AJR. American journal of roentgenology, 157 2
D. Vanel, L. Shapeero, T. Baère, R. Gilles, A. Tardivon, J. Génin, J. Guinebretière (1994)
MR imaging in the follow-up of malignant and aggressive soft-tissue tumors: results of 511 examinations.Radiology, 190 1
A. Geel, U. Pastorino, K. Jauch, I. Judson, F. Coevorden, J. Buesa, O. Nielsen, A. Boudinet, Tomas Tursz, P. Schmitz (1996)
Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer‐Soft Tissue and Bone Sarcoma Group study of 255 patientsCancer, 77
The strategy for the follow-up of soft tissue sarcomas (STS) after therapy is tailored to the individual risk of recurrence and based on efficient rather than sophisticated methods of observation. Along with advances in the treatment of sarcomas, earlier detection of a less advanced and resectable recurrent disease (local or metastasis—especially to the lungs) can prolong patient survival. Since the majority of STS relapses occur within 5 years after treatment (approximately 80 % of metastases to the lung and close to 70 % of local recurrences within the first 2–3 years), in the period between 2 and 3 years after treatment, it is mandatory to follow-up patients every 3 months and perform careful history and physical examination (especially scars after surgery of the primary site) and a chest X-ray. There is no reason to perform other studies in asymptomatic patients (unless the patient reports symptoms). In case of retroperitoneal or intraperitoneal STS (including gastrointestinal stromal tumor), contrast-enhanced computed tomography of the abdomen and pelvis is recommended as the follow-up modality of choice. In this paper we outline the current recommendations for the follow-up strategy.
memo - Magazine of European Medical Oncology – Springer Journals
Published: Jun 13, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.